Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

VedaBio has entered into agreement with Mammoth Biosciences to enhance its CRISPR-based molecular detection platform for ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.

Researchers developed TESLA-seq, a CRISPR-based method to map DNA regions that regulate genes. By scanning thousands of ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT ...

Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...